What is bipolar disorder?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Bipolar disorder treatment should prioritize a combination of medication and psychotherapy to stabilize mood and prevent recurrence of episodes, with a focus on lifestyle management and medication adherence to achieve stability and improve quality of life. When considering treatment options, it's essential to note that traditional mood stabilizers, such as lithium and valproate, and/or atypical antipsychotic medications are the primary treatment, with other psychotropic agents and psychotherapies generally used as adjunctive therapy or to address comorbid conditions and problems 1. Some key points to consider in treatment include:

  • Medication: Mood stabilizers such as lithium (600-1200 mg/day), valproate (750-1500 mg/day), or lamotrigine (100-200 mg/day), often combined with atypical antipsychotics like quetiapine (300-800 mg/day), olanzapine (5-20 mg/day), or aripiprazole (10-30 mg/day) 1
  • Psychotherapy: Therapy approaches like cognitive behavioral therapy (CBT) and interpersonal therapy are also essential components of treatment 1
  • Lifestyle management: Maintaining regular sleep patterns, avoiding alcohol and recreational drugs, managing stress, and recognizing early warning signs of mood episodes are crucial for achieving stability and improving quality of life 1 It's also important to address the associated functional and developmental impairments and the frequent need for support and skills building, as well as preexisting behavior disorders, substance abuse disorders, learning problems, and confounding psychosocial issues 1. By prioritizing a comprehensive treatment approach that combines psychopharmacology with adjunctive psychosocial therapies, individuals with bipolar disorder can achieve stability and lead fulfilling lives, with a focus on medication adherence and lifestyle management to prevent relapse and improve quality of life.

From the Research

Treatment Options for Bipolar Disorder

  • Mood stabilizers, such as lithium and valproate, are commonly used to treat bipolar disorder 2, 3, 4, 5
  • Atypical antipsychotics, such as quetiapine and olanzapine, can be used as augmentation therapy with mood stabilizers to improve treatment outcomes 2, 4, 5
  • Antidepressants are not recommended as monotherapy for bipolar disorder due to the risk of inducing mania or hypomania 4

Lithium Treatment

  • Lithium has been shown to be effective in preventing relapse of both mania and depression in bipolar disorder 6, 3, 4
  • The optimal dosing schedule for lithium is still debated, with options including multiple daily doses, single daily doses, and alternate daily doses 6
  • Single daily dosing may have advantages in reducing the risk of long-term renal damage and increasing compliance 6

Valproate Treatment

  • Valproate may be more effective as an antimanic agent rather than a prophylactic agent 3
  • Valproate may be a better choice for patients with many previous affective episodes or hospitalizations and psychiatric comorbidities 3

Diagnosis and Treatment Challenges

  • Bipolar disorder is often misdiagnosed or underdiagnosed, leading to delayed treatment and poor outcomes 4, 5
  • Non-adherence to treatment is a significant issue, with over 50% of patients not adhering to their treatment plan 4
  • Bipolar disorder is associated with a range of comorbidities, including metabolic syndrome, obesity, and type 2 diabetes, which can contribute to early mortality 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Lithium and Valproate in Bipolar Disorder: From International Evidence-based Guidelines to Clinical Predictors.

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.